Tag: gMG treatment developments
New Data on gMG Management Presented at 2024 AANEM Annual Meeting & MGFA Scientific...
UCB, a global biopharmaceutical company, recently announced that it will be presenting new data on generalized myasthenia gravis (gMG) treatments at the 2024 American...